Company Filing History:
Years Active: 2014
Title: Scott Daniels: Innovator in Gastrointestinal Treatment
Introduction
Scott Daniels is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of medicine, particularly in the treatment of gastrointestinal disorders. His innovative approach has led to the development of a unique method for treating functional dyspepsia and irritable bowel syndrome.
Latest Patents
Scott Daniels holds a patent for a formulation known as Val (8) GLP-1 composition. This patent outlines a method for treating functional dyspepsia and/or irritable bowel syndrome in mammals. The method involves administering a formulation by inhalation, which avoids first-pass metabolism of the active ingredient. This innovative approach utilizes a diketopiperazine and a glucagon-like peptide (GLP-1) analog, specifically ROSE-010.
Career Highlights
Scott Daniels is associated with Mannkind Corporation, where he has been instrumental in advancing research and development in gastrointestinal treatments. His work has garnered attention for its potential to improve the quality of life for individuals suffering from these conditions.
Collaborations
Scott has collaborated with notable colleagues, including Peter Richardson and Enda Kenny. Their combined expertise has contributed to the success of their projects and innovations.
Conclusion
Scott Daniels exemplifies the spirit of innovation in the medical field, particularly in the treatment of gastrointestinal disorders. His contributions through patents and collaborations highlight the importance of research and development in improving patient care.